Categories AlphaGraphs, Earnings, Health Care
DGX Infographic: Highlights of Quest Diagnostics’ Q4 2022 earnings
Quest Diagnostics Incorporated (NYSE: DGX) has announced financial results for the fourth quarter of 2022, reporting a sharp decline in adjusted profit and revenues.
On an adjusted basis, the healthcare company reported a net income of $1.98 per share for the December quarter, which is down 41% from the year-ago period. Unadjusted profit fell sharply to $101 million or $0.87 per share.
The bottom line was negatively impacted by a 15% decrease in revenues to $2.33 billion. The management expects full-year 2023 earnings to be between $7.61 per share and $8.21 per share.
“Quest had another strong year in 2022, with base business revenues growing more than 6% in the fourth quarter, and 5% for the full year. COVID-19 testing revenues declined as expected but still exceeded $1.4 billion in 2022,” said Quest’s CEO Jim Davis.
Most Popular
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731
Key takeaways from Visa’s Q3 2024 earnings report
Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in
Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024
Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%
